MSc Artificial Intelligence for Drug Discovery in London United Kingdom | Queen Mary University of London

Artificial Intelligence is transforming pharmaceutical research, enabling the creation of more effective treatments in less time. This Master's program equips students with fundamental drug discovery principles and AI methodologies. Through rigorous coursework, participants will acquire sophisticated computational abilities needed to implement AI solutions in pharmaceutical development. Designed for Chemistry, Pharmaceutical Chemistry, Medicinal Chemistry, Biochemistry, or similar graduates, this course prepares students for careers in this expanding sector. As one of the pioneering programs globally specializing in AI for drug development, it provides comprehensive training in cutting-edge computational techniques and programming languages including Python, TensorFlow, DeepChem, and AlphaFold. No previous coding experience is required, making it perfect for chemistry graduates seeking to specialize in AI applications for drug research. Queen Mary's Chemistry department ranks 8th in the UK for research impact (REF 2021), with instruction from renowned computational chemistry experts. Program Overview This curriculum prepares graduates for computational drug discovery careers. Students will master advanced computing techniques, including Python programming and implementation of machine/deep learning algorithms specific to pharmaceutical research, along with result interpretation and quality assessment. The program establishes core drug discovery competencies, covering molecular design for target protein binding and chemical structure optimization. Participants will apply computational methods to pharmaceutical challenges through scientific computing coursework and biomolecular modeling/simulation techniques.